| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |